1. Search Result
Search Result
Results for "

CD44v6

" in MedChemExpress (MCE) Product Catalog:

1

Inhibitors & Agonists

2

Inhibitory Antibodies

Cat. No. Product Name Target Research Area Image
  • HY-P99281

    BIWA 4; Anti-CD44 Recombinant Antibody

    Inhibitory Antibodies Cancer
    Bivatuzumab (Anti-CD44 Recombinant Antibody; BIWA 4) is a humanized monoclonal antibody directed against CD44v6. CD44v6 could acts as a sarcoma target for CAR-redirected CIK cells .
    Bivatuzumab
  • HY-P991922

    Fc Receptor (FcR) Complement System Radionuclide-Drug Conjugates (RDCs) Cancer
    AKIR001 is a high-affinity human IgG1 antibody targeting CD44v6. AKIR001 carries LALA-silencing mutations in its FcγR-binding domain to reduce FcγR and C1q interactions, minimizing tissue interactions and limiting CDC and ADCC risks. [ 177Lu] radiolabeled AKIR001, namely [ 177Lu]Lu-AKIR001, has anticancer activity against epidermoid carcinoma .
    AKIR001

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: